Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 5
2005 1
2006 1
2007 2
2008 3
2009 1
2012 2
2013 6
2014 2
2015 1
2016 3
2017 1
2018 6
2019 4
2020 5
2021 6
2022 5
2023 3
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Integrative genomic analysis identifies unique immune environments associated with immunotherapy response in diffuse large B cell lymphoma.
Tumuluru S, Godfrey JK, Cooper A, Yu J, Chen X, MacNabb BW, Venkataraman G, Zha Y, Pelzer B, Song J, Duns G, Sworder BJ, Bolen C, Penuel E, Postovalova E, Kotlov N, Bagaev A, Fowler N, Smith SM, Alizadeh AA, Steidl C, Kline J. Tumuluru S, et al. Among authors: zha y. bioRxiv [Preprint]. 2024 Apr 5:2024.01.17.576100. doi: 10.1101/2024.01.17.576100. bioRxiv. 2024. PMID: 38328071 Free PMC article. Preprint.
TIGIT is a key inhibitory checkpoint receptor in lymphoma.
Godfrey J, Chen X, Sunseri N, Cooper A, Yu J, Varlamova A, Zarubin D, Popov Y, Jacobson C, Postovalova E, Xiang Z, Nomie K, Bagaev A, Venkataraman G, Zha Y, Tumuluru S, Smith SM, Kline JP. Godfrey J, et al. Among authors: zha y. J Immunother Cancer. 2023 Jun;11(6):e006582. doi: 10.1136/jitc-2022-006582. J Immunother Cancer. 2023. PMID: 37364933 Free PMC article.
Highly aneuploid non-small cell lung cancer shows enhanced responsiveness to concurrent radiation and immune checkpoint blockade.
Spurr LF, Martinez CA, Kang W, Chen M, Zha Y, Hseu R, Gutiontov SI, Turchan WT, Lynch CM, Pointer KB, Chang P, Murgu S, Husain AN, Cody B, Vokes EE, Bestvina CM, Patel JD, Diehn M, Gajewski TF, Weichselbaum RR, Chmura SJ, Pitroda SP. Spurr LF, et al. Among authors: zha y. Nat Cancer. 2022 Dec;3(12):1498-1512. doi: 10.1038/s43018-022-00467-x. Epub 2022 Nov 28. Nat Cancer. 2022. PMID: 36443406 Clinical Trial.
59 results